Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Research Report 2024

Publication ID:

PB503243899

Publication Date:

March 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Transcatheter Aortic Valve Implantation (TAVI) System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Aortic valve stenosis is one of the most common and severe valve diseases in the elderly, and the incidence significantly increases with the age of patients. In western countries, the incidence rate of aortic stenosis is about 2% in people aged 65 years and above, and about 4% in people aged 85 years and above. Without timely intervention, the median survival period of patients is 2-3 years. Transcatheter aortic valve implantation (TAVI), as an interventional treatment procedure used in clinical practice in recent years, provides an ideal alternative treatment for high-risk patients with aortic valve stenosis who cannot tolerate surgical aortic valve replacement. With the increasing aging population and the expansion of indications, it is expected that the global number of TAVI surgeries will increase fourfold in the next few years, and the market size of transcatheter aortic valve implantation (TAVI) systems is expected to continue to increase.
This report aims to provide a comprehensive presentation of the global market for Transcatheter Aortic Valve Implantation (TAVI) System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Aortic Valve Implantation (TAVI) System.
Report Scope
The Transcatheter Aortic Valve Implantation (TAVI) System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcatheter Aortic Valve Implantation (TAVI) System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcatheter Aortic Valve Implantation (TAVI) System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abbott
Colibri
Boston Scientific
Medtronic
JenaValve Technology, Inc.
NVT AG
MicroPort
Segment by Type
Less than 20mm
20-25mm
Great than 25mm
Segment by Application
Elderly Patients
Other Patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcatheter Aortic Valve Implantation (TAVI) System companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Less than 20mm
1.2.3 20-25mm
1.2.4 Great than 25mm
1.3 麻豆原创 by Application
1.3.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Elderly Patients
1.3.3 Other Patients
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Perspective (2019-2030)
2.2 Transcatheter Aortic Valve Implantation (TAVI) System Growth Trends by Region
2.2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transcatheter Aortic Valve Implantation (TAVI) System Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Transcatheter Aortic Valve Implantation (TAVI) System Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Dynamics
2.3.1 Transcatheter Aortic Valve Implantation (TAVI) System Industry Trends
2.3.2 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Drivers
2.3.3 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Challenges
2.3.4 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcatheter Aortic Valve Implantation (TAVI) System Players by Revenue
3.1.1 Global Top Transcatheter Aortic Valve Implantation (TAVI) System Players by Revenue (2019-2024)
3.1.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcatheter Aortic Valve Implantation (TAVI) System Revenue
3.4 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Concentration Ratio
3.4.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcatheter Aortic Valve Implantation (TAVI) System Revenue in 2023
3.5 Transcatheter Aortic Valve Implantation (TAVI) System Key Players Head office and Area Served
3.6 Key Players Transcatheter Aortic Valve Implantation (TAVI) System Product Solution and Service
3.7 Date of Enter into Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcatheter Aortic Valve Implantation (TAVI) System Breakdown Data by Type
4.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Forecasted 麻豆原创 Size by Type (2025-2030)
5 Transcatheter Aortic Valve Implantation (TAVI) System Breakdown Data by Application
5.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size (2019-2030)
6.2 North America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2019-2024)
6.4 North America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size (2019-2030)
7.2 Europe Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2019-2024)
7.4 Europe Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size (2019-2030)
9.2 Latin America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Transcatheter Aortic Valve Implantation (TAVI) System Introduction
11.1.4 Abbott Revenue in Transcatheter Aortic Valve Implantation (TAVI) System Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Colibri
11.2.1 Colibri Company Detail
11.2.2 Colibri Business Overview
11.2.3 Colibri Transcatheter Aortic Valve Implantation (TAVI) System Introduction
11.2.4 Colibri Revenue in Transcatheter Aortic Valve Implantation (TAVI) System Business (2019-2024)
11.2.5 Colibri Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Detail
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Transcatheter Aortic Valve Implantation (TAVI) System Introduction
11.3.4 Boston Scientific Revenue in Transcatheter Aortic Valve Implantation (TAVI) System Business (2019-2024)
11.3.5 Boston Scientific Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Transcatheter Aortic Valve Implantation (TAVI) System Introduction
11.4.4 Medtronic Revenue in Transcatheter Aortic Valve Implantation (TAVI) System Business (2019-2024)
11.4.5 Medtronic Recent Development
11.5 JenaValve Technology, Inc.
11.5.1 JenaValve Technology, Inc. Company Detail
11.5.2 JenaValve Technology, Inc. Business Overview
11.5.3 JenaValve Technology, Inc. Transcatheter Aortic Valve Implantation (TAVI) System Introduction
11.5.4 JenaValve Technology, Inc. Revenue in Transcatheter Aortic Valve Implantation (TAVI) System Business (2019-2024)
11.5.5 JenaValve Technology, Inc. Recent Development
11.6 NVT AG
11.6.1 NVT AG Company Detail
11.6.2 NVT AG Business Overview
11.6.3 NVT AG Transcatheter Aortic Valve Implantation (TAVI) System Introduction
11.6.4 NVT AG Revenue in Transcatheter Aortic Valve Implantation (TAVI) System Business (2019-2024)
11.6.5 NVT AG Recent Development
11.7 MicroPort
11.7.1 MicroPort Company Detail
11.7.2 MicroPort Business Overview
11.7.3 MicroPort Transcatheter Aortic Valve Implantation (TAVI) System Introduction
11.7.4 MicroPort Revenue in Transcatheter Aortic Valve Implantation (TAVI) System Business (2019-2024)
11.7.5 MicroPort Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott
Colibri
Boston Scientific
Medtronic
JenaValve Technology, Inc.
NVT AG
MicroPort

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.